Medwave se preocupa por su privacidad y la seguridad de sus datos personales. Palabras clave: non-alcoholic fatty liver disease, liver steatosis, advanced glycation end products, liver fibrosis, adipocytokines. Se inicia con obesidad y sobrepeso. Figura 1. Aun cuando son muchos los tratamientos reportados, los resultados son controversiales.

Author:Maulmaran Zulunos
Language:English (Spanish)
Genre:Personal Growth
Published (Last):6 April 2004
PDF File Size:14.58 Mb
ePub File Size:7.12 Mb
Price:Free* [*Free Regsitration Required]

Non-alcoholic steatohepatitis. Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc, ; A wider view on diagnostic criteria of nonalcoholic steatohepatitis reply. Gastroenterology, ; Nonalcoholic fatty liver disease: the most common cause of abnormal liver enzymes in the U. Gastroenterology, ; Suppl :A Prevalence of and risk factors for hepatic stetosis in northern Italy.

Ann Intern Med, ; Prevalence of fatty liver in a general population of Okinawa, Japan. Jpn J Med, ; Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty. Prevalence of fatty liver in Japanase children and relationship to obesity: an epidemiological ultrasonographic survey. Dig Dis Sci, ; Liver involvement in obese children: ultrasonography and liver enzymes levels at diagnosis and during follow-up in an Italian population.

Fatty liver hepatitis steatohepatitis and obesity: an autopsy study with analysis of risk factors. Hepatology, ; Liver pathology in diabetes mellitus and morbid obesity. Clinical, pathological, and biochemical considerations. Pathol Annual, ; Liver pathology in morbidly obese patients with and witout diabetes. Am J Gastroenterol, ; Is liver biopsy useful in the evaluation of patients with chronically liver enzymes?. The natural history of non-alcoholic steatohepatitis: A follow-up study of forty-two patients for up to 21 years.

Clinicopathologic study of alcoholic-like liver diseasein non. Comparasion between non-alcoholic steatohepatitis and alcoholic hepatitis. Nonalcoholic steatohepatitis: An expanded clinical entity. Idiopathic stetohepatitis in childhood a multicenter retrospective study. J Pediatry, ; Steatohepatitis in obese children: a cause of chronic liver dysfunction. Nonalcoholic fatty liver disease:predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese.

Criptogenic cirrhosis: clinical characterization and risk factors for underlying disease. The liver in consecutive patients with morbid obesity: a clinical, morphological, and biochemical study.

Liver fibrosis in overweight patients. Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity.

J Hepatol, ; Gastroenterology, ;A Metabolic and nutritional considerations in nonalcoholic fatty liver. Hetalogy, ; Liver and biliary ultrasonography in diabetic and non-diabetic obese women. Diabetes Metab, ; Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: A manifestation of lipotoxicity. Hepatology, ;36 2 Nonalcoholic fatty liver, steatohepatitis, end the metabolic syndrome. Hepatology, ;37 4 Rashid M, Roberts EA.

Nonalcoholic steatohepatitis in children. J Pediatr Gastroenterol Nutr, ; Non-alcoholic steatohepatitis in children and adolescents. Med J Aust, ; Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.

Alcohol-like liver disease in nonalcoholics. A clinical and histologic comparation with alcohol-induced liver injury. Non-alcoholic steatohepatitis: Clinico-pathological comparation with alcoholic hepatitis in ambulatory and hospitalized patients. Acute and chronic hepatic steatosis lead to in vivo lipid peroxidation in mice. Journal of Hepatology, ; The biochemistry of alcohol-induced fatty liver.

Biochimica et Biophysica Acta, ; Fatty liver-an additional and treatable feature of the insulin resistance sydrome. QJM, ; Non-alcoholic steatohepatitis NASH : a disease of emerging identity and importance.

Journal or Hepatology, ; Chituri S, Farell GC. Etiopathogenesis of nonalcoholic steatohepatitis. Semin Liver Dis, ; Saltiel AR. Cell, ; Increased adipose tissue expression of tumor necrosis factor-a in human obesity and insulin resistance. J Clin Invest, ; Protection from obesity-induced insulin resistence in mice lacking TNF-a function. Nature, ; Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat.

Plasma transforming growth factor-b1 level and efficacy of a-tocopherol in patientes witn non-alcoholic steatohepatitis: a pilot study. Aliment Pharmscol Ther, ; Nonalcoholic steatosis and steatohepatitis. Cytochrome P enzymes and oxidative stress. Am J Physiol, ;GG J Clin Inves, ; James O, Day C. Non-alcoholic steatohepatitis: another disease of affluence. The Lancet, ; Association of Nonalcoholic faty liver disease with insulin resistence.

The American Journal of Medicine, ; Unsuspected cirrhosis discoveres during obesity operations. Arch Surg, ; Two cases from the spectrum of nonalcoholic steatohepatitis. J Clin Gastroenterol, ; Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying disease.

Trauner M, Graziadei IW. Mechanisms of action and therapeutic applications of ursodeoxycholic acid in chronic liver diseases. Alimentary Pharmacology Therapeutics, ; Betaine, a promising new agent for patients with nonalcoholic steatohepatitis:results of a pilot study. Treatment of non-alcoholic steatohepatitis with N acetylcisteine. Lavine JE. Vitamin E treatment of nonalcoholc steatohepatitis in children: a pilot study.

J Pediatr, ; Metformin in non-alcoholic steatohepatitis. Lancet, ; A controlled trial of gemfibrozil in the treatment on patients with nonalcoholic steatohepatitis.


2005, NĂºmero s1

Non-alcoholic steatohepatitis. Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc, ; A wider view on diagnostic criteria of nonalcoholic steatohepatitis reply.


Its pages are open to the members of the Association, as well as to all members of the medical community interested in using this forum to publish their articles in accordance with the journal editorial policies. The principal aim of the journal is to publish original work in the broad field of Gastroenterology, as well as to provide information on the specialty and related areas that is up-to-date and relevant. The scientific works include the areas of Clinical, Endoscopic, Surgical, and Pediatric Gastroenterology, along with related disciplines. The journal accepts original articles, scientific letters, review articles, clinical guidelines, consensuses, editorials, letters to the Editors, brief communications, and clinical images in Gastroenterology in Spanish and English for their publication. CiteScore measures average citations received per document published. Read more. SRJ is a prestige metric based on the idea that not all citations are the same.



Related Articles